Cellectis Competitors and Similar CompaniesClear all

Allogene Therapeutics's competitors and similar companies include Cipla and UCB.

	Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 2018	Founding Date 1935	Founding Date 1928
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations South San Francisco, US HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 2263% decrease	Employees 27,764	Employees 9,052
Valuation ($)	Valuation ($) 585.5 m	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit €7.2b (FY, 2025)
Net income	Net income ($190.9m) (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income €1.6b (FY, 2025)